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Isoﬂavones have generated much attention due to their potential positive eﬀects in various diseases. Phytoestrogens especially
equol can be found in bovine milk, as feed ration for dairy cows is comprised of plants containing phytoestrogens. The aim of this
study was to analyze the changes in hepatic gene expression after dietary intake of milk high and low in isoﬂavones. In addition
to pelleted feed female NMRI mice were oﬀered water, water added either 17β-estradiol, equol, Tween 80, and milk high and low
in isoﬂavone content for a week. Gene expression was analyzed using an array qPCR kit. It was revealed that Tween 80 and 17β-
estradiol upregulated both phase I and phase II genes to the same extent whereas equol alone, high and low isoﬂavone milk did
not alter the expression of phase I genes but decreased the expression of phase II genes. This study shows that dietary isoﬂavones
can regulate the transcription of especially phase II liver enzymes which potentially could give rise to an increase in reactive oxygen
metabolites that may contribute to the development of cancer.
1.Introduction
In recent years isoﬂavones (a group of phytoestrogens) have
generated much attention both in science and in public
due to their potential health beneﬁcial eﬀects in relation
to diseases such as atherosclerosis, breast, endometrial, and
prostate cancer, but also osteoporosis reviewed by Duncan et
al., 2003 [1].
Especially leguminous plants, such as clover and soya
bean, have high natural contents of phytoestrogens, the most
predominant being daidzein, genistein, formononetin, and
biochanin. These phytoestrogens can be found in bovine
milk [2], as a large proportion of the feed ration for dairy
cows is comprised of leguminous plants. Apart from these
plant isoﬂavones, equol may also be present in bovine milk.
Equol is produced from daidzein in the rumen of cows and
the human intestine by the micro ﬂora [3, 4]. Equol is of
special interest since it may directly exert cancer preventive
eﬀects [5]. However, only about one third of people in the
Western populations can produce equol, likely due to the
large interindividual variability in the intestinal ﬂora.
As isoﬂavones can change the phase 1 and phase 2
metabolisms [6], they have the potential to change the
metabolism of endogenous compounds such as hormones
and xenobiotic compounds including drugs. This may cause
a change in homeostasis and/or change the oxidative tress of
liver which may give rise to cancer. Most of these studies,
however, have been made in vitro. A recent in vivo study
revealed that some dietary isoﬂavones could change the
oxidative metabolism of 17β-estradiol (E2) measured using
microsomes from the levers, but the activity of CYP1A,
CYP2B, and CYP3A did not change [7] indicating that the
changed metabolism of E2 could be caused by an altered
activity of ﬂavin-containing monooxygenases (FMOs).
The objective of this study was to investigate if bovine
milk high or low in isoﬂavones can alter the liver phase 1 and
phase II metabolism. The eﬀect of puriﬁed equol and E2 was
also studied to test if the eﬀects caused by isoﬂavones were
anestrogen-likemodiﬁcation. AsTween80(polyxyoethylene
sorbitan monooleate) was used as a solvent for E2 it was also
tested.BothE2andTween80wereadministeredviadrinking
water. The eﬀect was measured as changes in transcription of2 Journal of Toxicology
an array of liver enzymes coding for both phase I and phase
II enzymes and transporters.
2.MaterialandMethods
2.1. Milk and Chemicals. The high and low isoﬂavone milk
(HIM and LIM) tested in the present experiment were
obtained from a grazing study described in detail by Eriksen
et al. [8]. Bulk milk was obtained at the end of two 3-week
periods in May to June 2006 from cows grazing alfalfa (n =
12) (low isoﬂavon milk, LIM) and red clover (n = 12) (high
isoﬂavone milk, HIM) was pooled. The fat percentage of
the milk was determined according to the method described
earlier[9],andmilk wasstandardized toapproximately 1.5%
fat to simulate low-fat milk. The crude protein content was
determined as Dumas N × 6.25 (3.4 and 3.3% for HIM and
LIM, resp.). Milk was pasteurized in water bath (15min,
65
◦C )a n ds t o r e da t−20
◦C until further use.
The analysis of the milk for isoﬂavones was done
as described by Nielsen et al. [10]. Milk samples were
equilibrated to room temperature before the addition of
25μL prunetin (120ng/mL) as internal standard and 100μL
β-glucuronidase in order to extract aglycones of phytoestro-
gens. The mixture was incubated at 37
◦Cf o r1h o u ra n d
shaken vigorously every 15 minutes. After centrifugation
(10min at 4000rpm), both the creamy layer and the pre-
cipitate were discarded, while the liquid phase was recovered
and submitted to solvent extraction with hexane (3 × 3mL)
followed by ethyl acetate (3×3mL). The ethyl acetate extract
was evaporated to dryness under a ﬂow of nitrogen. The
residue was then resuspended in 500μL acetonitrile and a
LC-MS analysis was performed [10].
Cyclodextrin-encapsulated water soluble-17β-estradiol
(E2) waspurchasedfromSigma-Aldrich A/S (Brøndby, Den-
mark). Racemic equol (purity ∼99%) was purchased from
Gentaur Molecular Products BVBA (Brussels, Belgium). 1%
Tween 80 was added to dissolve equol in water and also
tested.
2.2. Animals and Treatment. NMRI (BomTac:NMRI) out-
bred albino dams with litters standardized at postnatal day
one to contain 11 female pups born on the same day were
purchased from Taconic (Lille Skensved, Denmark). The
pups were seven to eight days old on arrival. Animals were
delivered pooled (four dams with 44pups), and a dam
was randomly assigned 10-11 pups and housed individu-
ally under controlled lighting (12h light/dark cycles) and
temperature (21-22◦C) conditions. The dams were given
fresh water and fed the RM1 diet (Special Diets Services,
Witham, UK) ad libitum until the pups were weaned at day
15. The RM1 diet was chosen because of the low content of
phytoestrogens compared with other standard rodent diets
[11].Atweaning,pupswereweighedandrandomlyplacedin
cages containing 6–10pups per cage and randomly assigned
to test groups. All mice had free access to the RM1 diet
and milk or water. Mice receiving the milk treatments had
fresh milk daily. The mice were euthanized by dislocation
of the neck day 22 and a piece of the liver was taken out
and transferred to RNA later for the gene expression analysis
(Quiagen, Ballerup, Denmark). The experiment and all
procedures related to the handling of animals were approved
by the Danish Experimental Animal Inspectorate.
In experiment 1, mice were allocated to one of the
following treatments: Water alone (Control) (n = 9); low
isoﬂavone milk (LIM, n = 15); high isoﬂavone (HIM,
n = 15); 33 or 100ngE2/mL drinking water (n = 8). In
experiment 2 the treatments were as follows: Water alone
(Control, n = 10); 50μg/mL equol added to the drinking
water containing 1% Tween 80 (polyxyoethylene sorbitan
monooleate) (n = 10) to dissolve the equol. To test the
possibility that the inclusion of 1% Tween 80 in the drinking
water could aﬀect the water intake or gene expression, an
additional group of 10 mice were given drinking water
containing only 1% Tween 80.
2.3. Liver Gene Expression Analysis. Total RNA was isolated
from 8 animals from each group both from experiments
1 and 2. The RNA was isolated using the Nucleospin Kit
(Macherey Nagel, Duren, Germany) following the manufac-
turer’s manual. The reverse transcription and PCR were set
up using RT2 First strand Kit and RT2 SYBR Green qPCR
Master Mix from SABiosciences (Tebu-bio Aps. Roskilde,
Denmark). The reactions were set up according to the Kit
manuals.
The gene expression analysis was carried out using
Mouse Drug Metabolism array assay from SABiosciences.
Twoarrayplatesweresetupforeachgroupofanimals(4ani-
mals/plate). For each array, 4ug total RNA was used, 1ug of
total RNA from each animal. In the mouse drug metabolism
array, gene expression of 84 genes involved mainly in phase I
andphaseIImetabolismcanbeanalyzed(Table 1).Thearray
also includes negative and positive control and the follow-
ing 5 housekeeping genes: β glucuronidase, hypoxyanthine
guanine phosphoribosyl transferase 1, heat shock protein 90
α, glyceraldehyde-3-phosphate dehydrogenase, and β actin
in order to calculate expression changes. The average Cp
values for all 5 housekeeping genes were used to estimate
theexpressionchanges.SoftwaredevelopedbySABiosciences
especially for these arrays was used to calculate the changes
in gene expression.
3. Results
3.1. Phytoestrogens and Endogenous Estrogens in Milk. The
concentrations of isoﬂavones varied between the HIM and
LIM. Especially for the isoﬂavone metabolite equol the dif-
ferences were very pronounced, 1003ng/mL and 57,4ng/mL
for HIM and LIM, respectively (Table 2). Mainly due to
these diﬀerences, the total cumulative concentrations also
varied signiﬁcantly between HIM (1215ng/mL) and LIM
(118ng/mL). The endogenous concentration of estrogens in
milk, however, did not vary signiﬁcantly (Table 2).
From these result and based on the daily intake of milk in
the two groups, (see Nielsen et al. [10] for further details) the
total daily intake of phytoestrogens in mice was calculated
to be 425 and 3767ng/d for low and high isoﬂavones milk,Journal of Toxicology 3
Table 1: A list of functional gene groupings included in the array assay.
Drug Transporters:
Metallothioneins: Mt2, Mt3.
P - G l y c o p r o t e i nF a m i l y :A b c b 1 a ,A b c b 1 b ,A b c b 4 ,A b c c 1 ,G p i 1 .
Phase I Metabolising Enzymes:
P450 Family: Cyp11b2, Cyp17a1, Cyp19a1, Cyp1a1, Cyp1a2, Cyp27b1, Cyp2b10, Cyp2C29, Cyp2e1, Cyp4b1.
Phase II Metabolising Enzymes:
Carboxylesterases: Ces1, Ces2.
Decarboxylases: Gad1, Gad2.
Dehydrogenases: Adh1, Adh4, Adh5, Alad, Aldh1a1, Hsd17b1, Hsd17b2, Hsd17b3.
Glutathione Peroxidases: Gpx1, Gpx2, Gpx3, Gpx5, Gsta1, Gsta3, Gsta4, Gstm1, Gstm2, Gstm3, Gstm4, Gstm5, Gstp1, Gstt1, Gstz1, Lpo,
Mpo.
Hydrolases: Ephx1, Faah, Fbp1.
Kinases: Hk2, Pklr, Pkm2.
Lipoxygenases: Alox12, Alox15, Alox5, Apoe.
Oxidoreductases: Blvra, Blvrb, Cyb5r3 (Dia1), Gpx1, Gpx2, Gsr, Mthfr, Nos3, Nqo1, Srd5a1, Srd5a2.
Paraoxonases: Pon1, Pon2, Pon3.
Sulfotransferases: Chst1, Gsta3, Gstm2, Gstm3, Gstm5, Gstp1, Gstt1, Mgst1, Mgst2, Mgst3.
Transferases: Nat1, Nat2, Comt, Ggt1.
Other Genes Related to Drug Metabolism: Abp1, Ahr, Arnt, Asna1, Gckr, Marcks, Smarcal1, Snn.
Table 2: Total concentrations (free and conjugated) of the mea-
sured phytoestrogens (ng/ml) and endogenous estrogens E1 and E2
(pg/mL) in high (HIM) and low (LIM) isoﬂavone milk.
LIM HIM
Isoﬂavones
Formononetin∗ 10.7 ±0.22 0 .4 ±0.9
Biochanin A∗ 1.3 ±0.07 0
Glycitein∗ 5.9 ±0.11 0 .2 ±1.0
Daidzein∗ 0.3 ±0.02 5.7 ±0.05
Isoﬂavone metabolite
Equol∗ 57.4 ±0.9 1003 ±37
Flavone
Chrysin∗ 00 .4 ±0.02
Flavanone
Naringenin∗ 13.4 ±0.11 6 .5 ±0.7
Lignans
Matairesinol∗ 04 8 .5 ±5.5
Enterodiol∗ 4.0 ±0.04 2.6 ±0.2
Enterolactone∗ 24.6 ±0.41 1 .0 ±1.3
Coumestans
Coumestrol 0 0
Total∗ 118 1215
Estrone (E1) 566 ±17 503 ±17
17β-estradiol (E2) 64.6 ±56 0 .0 ±5
∗Statistically signiﬁcant diﬀerence between LIM and HIM.
respectively. The intake of estrogen was 323 and 186pg/d
for HIM and LIM, respectively. The equol-treated group was
given 115000ng/d of equol and the E2-treated group was
exposed to 200ng/d of estradiol.
3.2. Gene Expression Analysis. T h er e s u l tf o rg e n e sm o d u -
lated more than 2 times compared to control (the group
given water or water with 1% Tween 80) is presented
in Table 3. One % Tween 80 (A) and 17β-estradiol (F)
upregulated both phase I and phase II genes by 2.1–9.5
times and 2.2–25.4 times, respectively. Equol, compared to
water, only upregulated 4 genes and downregulated 2 genes,
but when equol was compared to 1% Tween 80, 19 genes
were regulated, 17 downregulated, and 2 upregulated. HIM
(D) and LIM (E) caused a decrease in expression of genes
catalyzing the phase II metabolism by 2. 1–5 times. An
increased expression was obtained for one gene, a transport
protein (metallothionein 2) in the LIM group, but not in the
HIM group. The average Cp for the 5 housekeeping genes in
each group varied from 20.3 to 20.9.
4. Discussion
The potential positive eﬀects of phytoestrogens have gen-
erated much attention by both the public and scientists,
whereas other eﬀects, that is, changes in liver metabolism
have not attracted the same attention. This study is the ﬁrst
to look into how cow’s milk diﬀering in content of especially
isoﬂavones aﬀects the expression of an array of genes in the
liver. The content of phytoestrogens in milk can vary as seen
for HIM and LIM depending on the composition of the diet
thatcowsarefed,andorganicmilkingeneralcontainshigher
concentrationsofisoﬂavonesespeciallyequol[2,12,13].The
amount of equol found in this studied HIM is the highest so
far reported, most likely due to the large proportion of red
clover in the ﬁelds where cows are grazing [10], as red clover
is known to contain high amounts of the equol precursors
formononetin and daidzein [13, 14].4 Journal of Toxicology
Table 3: A list of genes regulated more than 2 times up (bold) or down (italic). Regulation caused by: A Tween 1%, B equol, D HIM, E LIM,
and F 17-β estradiol compared to control (mice feed water) and C equol compared to Tween.
A B C D E F Symbol Description Ref. seq.
2.4 2.5 Abcb1b ATP-binding cassette, sub-family B NM 011075
2.7 2.5 2.5 3.8 Abp1 Amiloride binding protein 1 NM 029638
3.2 Aldh1a1 Aldehyde dehydrogenase family 1, NM 013467
2.1 2.8 Alox15 Arachidonate 15-lipoxygenase NM 009660
3.3 2.2 5.7 Alox5 Arachidonate 5-lipoxygenase NM 009662
Blvra Biliverdin reductase A NM 026678
3.4 4.2 3.1 4.7 Chst1 Carbohydrate (keratan sulfate Gal-6) NM 023850
7.4 2.6 2.9 12.2 Cyp11b2 Cytochrome P450, family 11, subfamily b. NM 009991
9 6.2 12.8 Cyp19a1 Cytochrome P450, family 19, subfamily a. NM 007810
2.3 2.4 2.1 3.2 Cyp1a1 Cytochrome P450, family 1, subfamily a, NM 009992
8.7 2.5 3.5 12.4 Cyp27b1 Cytochrome P450, family 27, subfamily b. NM 010009
2.1 Faah Fatty acid amide hydrolase NM 010173
2.5 2.4 6.1 5 4.3 4.3 Gad2 Glutamic acid decarboxylase 2 NM 008078
2.2 Ggt1 Gamma-glutamyltransferase 1 NM 008116
4.6 32 . 9 7.1 Gpx2 Glutathione peroxidase 2 NM 030677
2.4 Gpx5 Glutathione peroxidase 5 NM 010343
Gstm1 Glutathione S-transferase, mu 1 NM 010358
2.1 2.3 2.1 Gstp1 Glutathione S-transferase, pi 1 NM 013541
2.4 2 2.7 Hk2 Hexokinase 2 NM 013820
2.8 2.1 2.5 3.8 Hsd17b1 Hydroxysteroid (17-beta) dehydrogenase 1 NM 010475
2.1 2.11 2.8 3.4 Hsd17b3 Hydroxysteroid (17-beta) dehydrogenase 3 NM 008291
9.5 3.4 2.8 15.4 Lpo Lactoperoxidase NM 080420
2.1 2.2 Mpo Myeloperoxidase NM 010824
2.1 2.3 4.8 6.7 2.8 Mt2 Metallothionein 2 NM 008630
2.4 3.3 Mt3 Metallothionein 3 NM 013603
6.8 5.3 2.2 4.6 9.3 Nat1 N-acetyltransferase 1 (arylamine N-acetyltransf.) NM 008673
2.1 2.1 2.2 Nos3 Nitric oxide synthase 3, endothelial cell NM 008713
3 2 3.3 Pkm2 Pyruvate kinase, muscle NM 011099
2.2 2.3 2.2 2.5 Snn Stannin NM 009223
2.35 2.3 Srd5a2 Steroid 5 alpha-reductase 2 NM 053188
Both E2 and 1% Tween 80 aﬀect the liver gene expression
by increasing the expression of the same phase I and
phase II genes. This indicates that Tween 80 aﬀects the
liver metabolism the same way and to the same extent as
100ngE2/mL drinking water. Equol, when compared to
Tween 80 on the other hand, seems to exert an opposite
eﬀect as this isoﬂavone downregulates many of the same
genesasE2upregulates.Mostofthegenesthataremodulated
by equol are also altered by HIM and LIM indicating
that the concentration of equol in both types of cow’s
milk might be high enough to exert an eﬀect. No altered
expressions were found for the phase I enzymes which are
in concordance with earlier published results where the
enzymatic activities of the P450 isoenzymes were found to
be unchanged [7]. This indicates that the enzyme activity
of these enzymes is potentially only regulated (inhibited) at
proteinlevel.Unfortunately,thedecreaseinexpression ofthe
following phase II genes Chst1 (a sulfotransferase), Ggt (a
glutamyltransferase), Gstp1 (a gluthathione S- transferase),
and Nat1(a acetyltransferase) may have a negative eﬀect.
A decrease in enzymes catalysing the conjugation reactions
may cause an increase in the concentration of bioactivated
compounds in the liver. As these compounds can form
adduct to both proteins and DNA, they may be carcinogenic.
The antioxidant level in the cell may also be altered by both
milk types caused by a decrease in the levels of peroxidases
and decarboxylases. The oxidative stress, that this may
induce, can cause cell damage as the reactive metabolites can
start a destruction of the cell membrane.
Hydroxysteroid (17-beta) dehydrogenase 1 and 3
(Hsd17b1 and Hsd17b3) catalyses the conversion of estrone
to the more reactive estradiol and androstenodione to
androgen testosterone, respectively [15, 16], and the
concentration of this enzymes is very high in the liver.
Inhibitors of Hsd17b1 are currently being developed for
use in therapy of hormone-dependent breast cancers as this
will give a lower concentration of the active estradiol [17].
The reduction in protein level of this enzyme caused by
the milk may explain the positive eﬀect of phytoestrogens
on breast cancer found in some studies [1]. MutationsJournal of Toxicology 5
in the Hsd17b3 genes occur in humans and can cause
male pseudohermaphroditism or feminization because of
decreased function [18]. A decrease in the gene expression
of this gene is seen after exposure to both types of milk,
and it may therefore be able to induce feminization.
Also development of cancers of colon, breast, uterus,
endometrium, and prostate has been hypothesized to be
promoted by loss of activity of Hsd17B1 and Hsd17b3 as
reviewed by Vihko et al. [19]
Equol and HIM also induced a decrease in mRNA coding
for amiloride-binding protein (amine oxidase, Abp1). This
enzyme catalyzes the oxidative deamination compounds
such as histamine [20] and may therefore aﬀect clinical
diseases related to histidin, that is, asthma and allergic
rhinitis [21]. High plasma levels of this enzyme have been
observed in human cancer but as the concentration of this
enzyme decreases, no carcinogenic eﬀect with regard to this
system is expected.
From this study it can be concluded, that both HIM and
LIM induce changes in hepatic gene expression likely due
to the presence of isoﬂavones since the genes aﬀected are
also aﬀected by equol. The decrease in phase II enzymes
could potentially give rise to epigenetic actions contributing
to carcinogenesis by increasing the level of reactive oxygen
metabolites. The use of Tween 80 in future in vivo studies
should be considered because of its eﬀect on hepatic
metabolism.
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